SCHEMBL19852487

SCHEMBL19852487

c1ccc(C2COC3(CCN(CC4c5ccccc5CC4c4ccc5c(c4)CC[C@H]5CN4CCC5(CC4)C[C@H](c4ccccc4)CO5)CC3)C2)cc1

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HRH1 P35367 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CCR5 P51681 1/20 0.33
OPRM1 P35372 1/20 0.31
OPRL1 P41146 1/20 0.31
MGLL Q99685 2/20 0.31
ADRA2A P08913 4/20 0.31
ADRA2B P18089 4/20 0.31
ADRA2C P18825 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21071570 0.85 SIGMAR1 (0.41) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL19838621 0.85 SIGMAR1 (0.41) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL21071569 0.85 SIGMAR1 (0.41) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL19852495 0.85 SIGMAR1 (0.41) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL21071634 0.85 SIGMAR1 (0.41) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL21071451 0.85 SIGMAR1 (0.41) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL21071454 0.85 SIGMAR1 (0.41) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL19852237 0.75 HTR2A (0.37) HTR2AHTR2CHRH1TMEM97SIGMAR1
SCHEMBL19852493 0.71 OPRL1 (0.39) SIGMAR1OPRM1OPRL1
SCHEMBL19852490 0.71 OPRL1 (0.39) SIGMAR1OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed